Mycophenolate mofetil and Cyclophosphamide drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Mycophenolate mofetil (mycophenolate mofetil) and Cyclophosphamide (cyclophosphamide). Common drug interactions include neutropenia among females and drug ineffective among males.
The phase IV clinical study analyzes what interactions people have when they take Mycophenolate mofetil and Cyclophosphamide. It is created by eHealthMe based on reports of 9,358 people who take the same drugs from the FDA, and is updated regularly.
What is Mycophenolate mofetil?
Mycophenolate mofetil has active ingredients of mycophenolate mofetil. It is often used in myasthenia gravis. eHealthMe is studying from 93,460 Mycophenolate mofetil users. Check the latest studies of Mycophenolate mofetil.
What is Cyclophosphamide?
Cyclophosphamide has active ingredients of cyclophosphamide. It is often used in multiple myeloma. eHealthMe is studying from 185,240 Cyclophosphamide users. Check the latest studies of Cyclophosphamide.
9,358 people who take Mycophenolate mofetil and Cyclophosphamide together, and have interactions are studied.
What are the common drug interactions of Mycophenolate mofetil and Cyclophosphamide, by gender? *
What are the common drug interactions of Mycophenolate mofetil and Cyclophosphamide, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Mycophenolate mofetil and Cyclophosphamide?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Mycophenolate mofetil (93,460 reports)
- Cyclophosphamide (185,240 reports)
Browse all drug interactions of Mycophenolate mofetil and Cyclophosphamide:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Mycophenolate mofetil:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Cyclophosphamide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Mycophenolate mofetil and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cyclophosphamide and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .
- Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .
How the study uses the data?
The study uses data from the FDA. It is based on mycophenolate mofetil and cyclophosphamide (the active ingredients of Mycophenolate mofetil and Cyclophosphamide, respectively), and Mycophenolate mofetil and Cyclophosphamide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Tussionex Pennkinetic and Simvastatin - 3 seconds ago
- Tuberculosis and Gout - 14 seconds ago
- Could Ajovy cause Blindness? - 23 seconds ago
- Could Luvox cause Musculoskeletal Pain? - 37 seconds ago
- Idiopathic Thrombocytopenic Purpura (Itp) and Tooth Abscess - 50 seconds ago
- Could Imuran cause Thrombocytopenia? - 52 seconds ago
- Drug interactions of Nifedipine and Cellcept - a minute ago
- Linezolid vs. Cefdinir, side effect and effectiveness comparison - a minute ago
- Could Temaz cause Musculoskeletal Chest Pain? - a minute ago
- Drug interactions of Tramadol and Epiduo - 2 minutes ago